Photobiomodulation and the Intralesional Administration of Corticoid in the Keloid Surgery.

Not Applicable

Completed

• Conditions: Keloid; Cicatrix

• Registration Number: NCT04824612
• Lead Sponsor: University of Nove de Julho

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-3-24
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 4

Inclusion Criteria

Inclusion Criteria:<br><br> - Age: 18 to 65 years;<br><br> - Fitzpatrick skin phototype I-VI;<br><br> - Keloid with no type of previous treatment;<br><br> - Recurring keloid after surgical excision;<br><br> - Recurring keloid after use of other therapies and at least three months without<br> treatment.<br><br>Exclusion Criteria:<br><br> - Keloid in treatment;<br><br> - Pregnant and lactating women;<br><br> - Keloid with primary synthesis of the skin and no possibility of excision.<br><br> - Contraindications for undergoing surgery (e.g.: coagulopathies, diabetes myellitus,<br> drug allergies);<br><br> - Contraindications for the use of corticosteroids;<br><br> - All types of Collagenosis.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
scar assessment by specialists (change in the scar of is being evaluated);Quality of Life of the patients (change in quality of life is being evaluated);patient satisfaction with the scar (change in the quality of scar is being evaluated)

Secondary Outcome Measures

Name	Time	Method
keloid and remaining scar size;Fibroblasts analysis;analysis of collagen;analysis of TGF-ß